NEW YORK, Jan 2 – Bayer and Zymark of Hopkinton, Mass. have developed a cell-based assay kit that allows laboratories to design assays for any gene target or type of cell and run an automated assay, the companies announced Tuesday.
The package includes Bayer’s QuantiGene assays, HV kit, and ProbeDesigner software, as well as Zymark’s Staccato workstation.
The QuantiGene assay and HV kit is designed to measure the expression of cellular mRNA without the sample preparation phase. The ProbeDesigner software allows a researcher to design specific probes for mRNA targets.
According to Bayer, the Staccato workstation can complete 10,000 assays in 24 hours, and can be adapted easily for assays on different gene targets.
" Through the collaboration with Zymark, our companies are able to provide an assay solutions package employing innovative mRNA quantitation technology and the latest in high-throughput automation,” said Stephen Chamberlain, senior marketing manager for QuantiGene technologies at Bayer. “We are helping laboratories streamline their lead identification and validation processes by providing the means to obtain data of high value, eliminating the time required to develop the assay, and shortening the overall run time.”